Sponsors (6)
The bill broadly expands no-cost access to validated home blood pressure monitors for pregnant and postpartum people—improving monitoring and equity across payers—while imposing added costs on taxpayers/insurers, implementation burdens on states, and access limits tied to device approval and replacement rules.
Pregnant and postpartum individuals enrolled in Medicaid, CHIP, alternative benefit plans, and private group and individual health plans will receive a validated home blood pressure monitor with no cost-sharing for pregnancy and the 12-month postpartum period, expanding access across payer types.
Pregnant and postpartum individuals will have access to accurate, clinically reliable devices because covered monitors must be FDA 510(k)-cleared and listed on the AMA-recognized validated devices list.
Low-income pregnant and postpartum people covered by CHIP and alternative benefit plans are explicitly included, reducing disparities in access to home hypertension monitoring.
Taxpayers and private insurers will face higher costs from mandatory coverage and elimination of cost-sharing, which could raise premiums or increase government spending.
Requiring devices to be FDA 510(k)-cleared and on the AMA listing may exclude lower-cost or newer innovative monitors not yet cleared or listed, delaying access for some users, particularly low-income individuals.
Limiting coverage to one device per two-year period could leave pregnant or postpartum individuals who need replacements or multiple devices without coverage, reducing the practical benefit for those cases.
Based on analysis of 2 sections of legislative text.
Requires Medicaid/CHIP to cover FDA‑cleared, AMA‑validated self-measured blood pressure devices for pregnant and postpartum individuals with no cost‑sharing and a one-device-per-2-year limit.
Official title: To amend titles XIX and XXI of the Social Security Act, title XXVII of the Public Health Service Act, the Employee Retirement Security Act of 1974, and the Internal Revenue Code of 1986 to require coverage of self-measured blood pressure monitoring for pregnant and postpartum individuals.
Introduced May 7, 2026 by Nikema Williams · Last progress May 7, 2026
Requires Medicaid and CHIP plans to cover self-measured blood pressure monitoring devices for pregnant and postpartum individuals without cost‑sharing, defines eligible devices, and limits device coverage to one per person every two years. It also requires benchmark and alternative benefit plans used in Medicaid expansion/alternative coverage to include this coverage beginning 120 days after enactment.